Results 241 to 250 of about 320,891 (294)

Tuberculosis Vaccines: Multidimensional Exploration and Breakthroughs from Innovative Design to Evaluation Systems. [PDF]

Vaccines (Basel)
Gong W, Aspatwar A.
europepmc   +1 more source

An Enzyme‐Like Catalyzed Nanosheets for Redox Stress Oscillation Therapy Against Bacterial Infections

Advanced Science, EarlyView.
Bacterial biofilms form a physicochemical barrier. Their dense network structure and redox homeostasis confer high resistance to antimicrobial treatments and immune‐mediated killing and clearance. In this study, SnSe nanosheets with enzyme‐like properties and piezoelectric catalysis can oscillate to regulate bacterial redox homeostasis and improve the ...
Min Ge, Zhao Guo, Zhiming Zhang, Lanlu Lu, Zesong Ruan, Tingwang Shi, Yunfeng Chen, Ju Huang, Chaoliang Tan, Han Lin   +9 more
wiley   +1 more source

Tuberculosis vaccination: microbiological and immunological summary of a series of experimental challenge studies. [PDF]

Vet Res
Juste RA, Sevilla IA, Minguijon E, Fuertes M, Elguezabal N, Geijo M, Vazquez P, Serrano M, Rakel A, Gortazar C, Etxezarreta A, Molina E, Garrido JM.   +12 more
europepmc   +1 more source

CRISPR‐Cas9‐Loaded Theranostic Liposomes for Enhancing Radiosensitization of Prostate Cancer through POLD4 Gene Editing under Real‐Time MRI Monitoring

Advanced Science, EarlyView.
This study identifies POLD4 as a potential prostate cancer radiosensitization target through transcriptome sequencing. By encapsulating POLD4‐targeted CRISPR/Cas9 plasmids and USPIONs in cationic liposomes, an MRI‐monitored gene‐editing platform is established.
Xuhui Fan, Ruru Zhang, Linjun Yang, Shixiong Chen, Meijuan He, Yongqiang Wang, Linjie Huang, Jianfeng Zeng, Shuwang Wu, Mingyuan Gao, Han Wang   +10 more
wiley   +1 more source

Infection with Helicobacter pylori and the age at onset of coeliac disease in the "HUNT4" survey. [PDF]

BMC Res Notes
Melby KK, Hjort R, Lundin KEA, Ness-Jensen E.   +3 more
europepmc   +1 more source

Identification of Mannose‐Capped‐Arabinomannan 101‐mer as a Potential Influenza Virus Vaccine Adjuvant

Advanced Science, EarlyView.
Well‐defined and synthetic mannose‐capped arabinomannan 101‐mer from Mycobacterium tuberculosis cell wall was identified as a potent influenza vaccine adjuvant, boosting the antibody response, realizing full protection and showing excellent safety. ABSTRACT Many natural bacterial components as adjuvants can activate the host immune system, but the ...
Yu‐Fang Zhang, Ruihong Xu, Jia Luo, Yuxin Ma, Guozhi Xiao, Ye Liu   +5 more
wiley   +1 more source

Engineering strategies and biomedical applications of bacterial extracellular vesicles. [PDF]

Biomater Transl
Liang X, Li Q, Zheng L, Situ B.
europepmc   +1 more source

Different antibody isotypes against tuberculosis: what we know and what we need to know. [PDF]

Front Immunol
Li H, Li H.
europepmc   +1 more source

Diagnostic value of procalcitonin for identifying the etiology of lower respiratory tract infections: a systematic review and meta-analysis. [PDF]

BMC Infect Dis
Lin CY, Zhou X, Li GG, Qiu J, Li D, Pang QY.   +5 more
europepmc   +1 more source